To meet the increasing market demand, ZETA, the biomanufacturing facility design expert, established its North American engineering hub in Greater Philadelphia in August 2021, providing ultra-fast-track project delivery. Today, ZETA USA announced it is well established and actively implementing US-based and multi-national projects for leading pharma and biotech companies.
ZETA has established itself internationally as a one-stop-shop for the biopharmaceutical industry. With ZETA's opening of its new subsidiary in Singapore, Asian companies in the pharmaceutical and biotech industries can now also benefit from customer-specific services on-site.
The ZETA Group has established itself worldwide as a highly competent partner in implementing large-scale biopharmaceutical projects. The sustainable expansion of the team at the Moscow location now makes it possible to offer targeted services for Russian pharmaceutical and biotech companies, particularly in the area of general planning.
The ZETA Group is an end-to-end solution provider operating globally and specializing in the design, construction, automation, digitalization and qualification of customer-specific biopharmaceutical systems for aseptic process solutions. As EPCM contractor, ZETA manages major, high-complexity pharma projects and specifically reduces interfaces—from the planning and construction of the process system through the cleanroom design up to the technical building infrastructure.
Join us for a look behind the scenes.
ZETA on Tour: International presence at conferences, trade fairs and industry events.
